Ending Federal Marijuana Prohibition Act of 2011

S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues related to legalizing marijuana Issues related to appropriations for Byrne-Jag grants, COPS, drug courts, Second Chance Act funding.

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Public Law 111-203 - Dodd Frank Act (Rulemakings and Implementation) H.R. 31 - Fannie Mae and Fredie Mac Accountability and Transparency for Taxpayers Act H.R. - The Security in Bonding Act Public Law 112-106 - Jumpstart Our Business Startups Act (Rulemaking and Implementation) H.R. 2306 - SEC Regulatory Accountability Act H.R. 1838 - To repeal a provision of the Dodd-Frank Wall Street Reform and Consumer Protection Act that disadvantages U.S. financial institutions by forcing them to move their swap desks to a separately registrered and capitalized entity. H.R. 3871 - Proprietary Information Protection Act of 2012 H.R. 2483 - Whistleblower Improvement Act of 2011 H.R. 5860 - Executive Compensation Clawback Full Enforcement Act Public Law 112-105 - Stop Trading on Congressional Knowledge Act (The STOCK Act)

Client expense: $768,022 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

Lobbying in support of H.R. 2306, the Ending Federal Marijuana Prohibition Act, which would dramatically reduce the role of the federal government in marijuana prohibition. Lobbying in support of H.R. 1983, the States' Medical Marijuana Patient Protection Act, which would allow states to enact their own medical marijuana laws without federal interference or involvement. General lobbying related to the U.S. Department of Justice interfering with state medical marijuana laws. Lobbying in support of the Hinchey-Rohrabacher medical marijuana amendment to the CJS Approps bill.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration. H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues relating to legalizing marijuana. Issues related to federal prison spending.

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Public Law 111-203 - Dodd Frank Act (Rulemakings and Implementation) H.R. 31 - Fannie Mae and Freddie Mac Accountability and Transparency for Taxpayers Act H.R. 3534 - The Security in Bonding Act H.R. 3606 - Jumpstart Our Business Startups Act H.R. 2306 - SEC Regulatory Accountability Act H.R. 1838 - To repeal a provision of the Dodd-Frank Wall Street Reform and Consumer Protection Act that disadvantages U.S. financial institutions by forcing them to move their swap desks to a separately registered and capitalized entity. H.R. 3871 - Proprietary Information Protection Act of 2012 H.R. 2483 - Whistleblower Improvement Act of 2011 H.R. 5860 - Executive Compensation Clawback Full Enforcement Act Public Law 112-105 - Stop Trading on Congressional Knowledge Act (The STOCK Act)

Client expense: $491,523 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration H.R. 1254, Synthetic Drug Control Act of 2011, issues relating to Spice, "bath salts", and the scheduling system H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues relating to legalizing marijuana. H.AMDT.1084 to H.R.5326, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2013, issues related to medical marijuana. S. 2323, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2013, issues related to medical marijuana. H.R. 6020, Financial Services and General Government Appropriations Act, 2013, issues related to medical marijuana. Issues related to Byrne Grant funding. Issues related to federal prison spending.

Client expense: $160,000 · Firm income: Not reported

Lobbying in support of H.R. 2306, the Ending Federal Marijuana Prohibition Act, which would dramatically reduce the role of the federal government in marijuana prohibition. Lobbying in support of H.R. 1983, the States' Medical Marijuana Patient Protection Act, which would allow states to enact their own medical marijuana laws without federal interference or involvement. General lobbying related to the U.S. Department of Justice interfering with state medical marijuana laws. Lobbying in support of the Hinchey-Rohrabacher medical marijuana amendment to the CJS Approps bill.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Public Law 111-203 - Dodd Frank Act (Rulemakings and Implementation) Public Law 110-343 - TARP (Oversight) H.R. 31 - Fannie Mae and Freddie Mac Accountability and Transparency for Taxpayers Act H.R. 3534 - The Security in Bonding Act H.R. 3606 - Jumpstart Our Business Startups Act H.R. 2306 - SEC Regulatory Accountability Act H.R. 1838 - To repeal a provision of the Dodd-Frank Wall Street Reform and Consumer Protection Act that disadvantages U.S. financial institutions by forcing them to move their swap desks to a separately registered and capitalized entity. H.R. 3871 - Proprietary Information Protection Act of 2012 H.R. 2483 - Whistleblower Improvement Act of 2011

Client expense: $818,830 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration. H.R. 313, Drug Trafficking Safe Harbor Elimination Act of 2011, issues related to drug conspiracy law S. 1672, Drug Trafficking Safe Harbor Elimination Act of 2011, issues related to drug conspiracy law H.R. 1254, Synthetic Drug Control Act of 2011, issues related to Spice, "bath salts", and the scheduling system H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues relating to legalizing marijuana.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying in support of H.R. 2306, the Ending Federal Marijuana Prohibition Act, which would dramatically reduce the role of the federal government in marijuana prohibition. Lobbying in support of H.R. 1983, the States' Medical Marijuana Patient Protection Act, which would allow states to enact their own medical marijuana laws without federal interference or involvement. General lobbying related to the U.S. Department of Justice interfering with state medical marijuana laws.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying in support of H.R. 2306, the Ending Federal Marijuana Prohibition Act, which would dramatically reduce the role of the federal government in marijuana prohibition. Lobbying in support of H.R. 1983, the States' Medical Marijuana Patient Protection Act, which would allow states to enact their own medical marijuana laws without federal interference or involvement.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

S. 306, National Criminal Justice Act of 2011, issues related to over-incarceration H.R. 313, Drug Trafficking Safe Harbor Elimination Act of 2011, issues related to drug conspiracy law S. 1672, Drug Trafficking Safe Harbor Elimination Act of 2011, issues related to drug conspiracy law H.R. 1254, Synthetic Drug Control Act of 2011, issues related to Spice, "Bath Salts", and the scheduling system H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues relating to legalizing marijuana.

Client expense: $290,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support HR 2306, entitled the "Ending Federal Marijuana Prohibition Act of 2011," to eliminate federal laws that would interfere with a state's right to adopt whatever marijuana laws they might want. Support HB 1983, entitled the States' Medical Marijuana Patient Protection Act, to reschedule marijuana under federal law to permit states to legalize the medical use of marijuana without any conflict with federal law.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying in support of H.R. 2306, the Ending Federal Marijuana Prohibition Act, which would dramatically reduce the role of the federal government in marijuana prohibition. Lobbying in support of H.R. 1983, the States' Medical Marijuana Patient Protection Act, which would allow states to enact their own medical marijuana laws without federal interference or involvement.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

S. 306, National Criminal Justice Act of 2011, issues related to over-incarceration H.R. 313, Drug Trafficking Safe Harbor Elimination Act of 2011, issues related to drug conspiracy law H.R. 1254, Synthetic Drug Control Act of 2011, issues related to Spice, "Bath Salts", and the scheduling system FY 2012 Commerce, Justice, Science Appropriations bill, issues related to funding for Byrne/JAG and COPS programs H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues relating to legalizing marijuana

Client expense: $220,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocating for the introduction of a bill to dramatically reduce the role of the federal government in marijuana prohibition. Introduced on June 23, 2011 as H.R. 2306, the Ending Federal Marijuana Prohibition Act. Lobbying in support of H.R. 1983, the States' Medical Marijuana Patient Protection Act, which would allow states to enact their own medical marijuana laws without federal interference or involvement.

Client expense: $8,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration H.R. 2242, Fairness in Cocaine Sentencing Act of 2011, issues related to crack/powder cocaine sentencing disparity H.R. 2316 , Fair Sentencing Claification Act of 2011, issues related to crack/powder cocaine sentencing disparity H.R. 2303, Major Drug Trafficking Prosecution Act of 2011, issues related to mandatory minimum sentencing FY 2012 Commerce, Justice, Science Appropriations bill, issues related to funding for Byrne/JAG and COPS programs H.R. 2306, Ending Federam Marijuana Prohibition Act of 2011, issues relating to legalizing marijuana

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE